PDPN and neoplasm: The endogenous ligand of CLEC-2, podoplanin, could increase tumor cells motility by remodeling actin in the cytoskeleton and correlated with the onset of epithelial to mensenchymal transition (EMT), a key role in tumor metastasis [14, 15].